L'Hôtel-Dieu de Québec
Hôtel-Dieu de Québec
11 Côte du Palais, bureau 5212
Québec, Québec
Canada G1R 2J6

Dernières nouvelles

Information non disponible

Lavallee MC, Cantin A, Aubin S, Lefebvre M, Marrier AS, Bouchard I, Fiset C, Villeneuve-Gauthier A, Foster W, Martin AG, Carignan D, Beaulieu L, Vigneault E

US-guided EM tracked system for HDR brachytherapy: A first in-men randomized study for whole prostate treatment

Article de revue

Brachytherapy, 23 (1), 2024.

Résumé | Liens:

Ouellet S, Lemaréchal Y, Berumen-Murillo F, Lavallée MC, Vigneault É, Martin AG, Foster W, Thomson RM, Després P, Beaulieu L

A Monte Carlo dose recalculation pipeline for durable datasets: an I-125 LDR prostate brachytherapy use case

Article de revue

Phys Med Biol, 68 (23), 2023.

Résumé | Liens:

Beaudry MM, Carignan D, Foster W, Lavallee MC, Aubin S, Lacroix F, Poulin E, Lachance B, Després P, Beaulieu L, Vigneault E, Martin AG

Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial

Article de revue

Clin Transl Radiat Oncol, 40 , 2023.

Résumé | Liens:

Bélanger C, Poulin É, Aubin S, Vigneault É, Martin AG, Foster W, Beaulieu L

Inter-observer evaluation of a GPU-based multicriteria optimization algorithm combined with plan navigation tools for HDR brachytherapy

Article de revue

Brachytherapy, 21 (4), 2022.

Résumé | Liens:

Lavoie-Gagnon H, Martin AG, Poulin E, Archambault L, Pilote L, Foster W, Vigneault E, Carignan D, Lacroix F

Advantages of TRUS-based delineation for high-dose-rate prostate brachytherapy planning

Article de revue

J Contemp Brachytherapy, 14 (1), 2022.

Résumé | Liens:

Pinthus JH, Duivenvoorden WCM, Klotz L, Mukherjee SD, Siemens DR, Niazi T, Fradet V, Foster W, Duceppe E, Taussky D, Hamilton R, Lavallée L, Brown I, Chin J, Gopaul D, Wassef A, Kassouf W, Davis M, Violette PD, Agapay S, Balasubramanian K, Mian R, Rangarajan S, Sener A, Shayegan B, Devereaux PJ, Leong DP

Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy

Article de revue

J Urol, 207 (5), 2022.

Résumé | Liens:

Reynaud T, Hathout L, Carignan D, Barkati M, Martin AG, Foster W, Lacroix F, Delouya G, Taussky D, Morton G, Vigneault E

PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study

Article de revue

Brachytherapy, 20 (6), 2021.

Résumé | Liens:

Lavallée MC, Cantin A, Monéger F, Lefebvre M, Foster W, Vigneault E, Beaulieu L

Commissioning of an intra-operative US guided prostate HDR system integrating an EM tracking technology

Article de revue

Brachytherapy, 20 (6), 2021.

Résumé | Liens:

Signaler des ajouts ou des modifications